Literature DB >> 21597318

Mammalian prions: tracking the infectious entities.

Jimmy Savistchenko1, Zaira E Arellano-Anaya, Olivier Andréoletti, Didier Vilette.   

Abstract

Protein misfolding is central to the pathogenesis of several neurodegenerative disorders. Among these disorders, prion diseases are unique because they are transmissible. The conversion of the host-encoded GPI-anchored PrP protein into a structurally altered form is crucially associated with the infectious and neurotoxic properties of the resulting abnormal PrP. Many lines of evidence indicate that distinct aggregated forms with different size and protease resistance are produced during prion multiplication. The recent isolation of various subsets of abnormal PrP, along with the improved biochemical tools and infectivity detection assays have shed light on the diversity of abnormal PrP protein and may give insights into the features of the more infectious subsets of abnormal PrP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21597318      PMCID: PMC3166506          DOI: 10.4161/pri.5.2.16096

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  49 in total

Review 1.  Chemistry and biology of prions.

Authors:  S B Prusiner
Journal:  Biochemistry       Date:  1992-12-15       Impact factor: 3.162

Review 2.  Exosomes: a bubble ride for prions?

Authors:  Benoît Février; Didier Vilette; Hubert Laude; Graça Raposo
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

3.  Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis.

Authors:  M P McKinley; R K Meyer; L Kenaga; F Rahbar; R Cotter; A Serban; S B Prusiner
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Eight prion strains have PrP(Sc) molecules with different conformations.

Authors:  J Safar; H Wille; V Itri; D Groth; H Serban; M Torchia; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

5.  Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity.

Authors:  D Riesner; K Kellings; K Post; H Wille; H Serban; D Groth; M A Baldwin; S B Prusiner
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+].

Authors:  Y O Chernoff; S L Lindquist; B Ono; S G Inge-Vechtomov; S W Liebman
Journal:  Science       Date:  1995-05-12       Impact factor: 47.728

7.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

Review 8.  The intricate mechanisms of neurodegeneration in prion diseases.

Authors:  Claudio Soto; Nikunj Satani
Journal:  Trends Mol Med       Date:  2011-01       Impact factor: 11.951

9.  Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein.

Authors:  C I Lasmézas; J P Deslys; O Robain; A Jaegly; V Beringue; J M Peyrin; J G Fournier; J J Hauw; J Rossier; D Dormont
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

Review 10.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  3 in total

1.  Prion strains are differentially released through the exosomal pathway.

Authors:  Zaira E Arellano-Anaya; Alvina Huor; Pascal Leblanc; Sylvain Lehmann; Monique Provansal; Graça Raposo; Olivier Andréoletti; Didier Vilette
Journal:  Cell Mol Life Sci       Date:  2014-09-18       Impact factor: 9.261

2.  Formation of distinct prion protein amyloid fibrils under identical experimental conditions.

Authors:  Mantas Ziaunys; Tomas Sneideris; Vytautas Smirnovas
Journal:  Sci Rep       Date:  2020-03-12       Impact factor: 4.379

3.  A concise review of amyloidosis in animals.

Authors:  Moges Woldemeskel
Journal:  Vet Med Int       Date:  2012-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.